Massive Bio is a health-tech company transforming how cancer patients access clinical trials.
Operating in 17 countries across North America, Europe, and LATAM, we use proprietary AI technology to match patients to the most appropriate clinical trials—regardless of location, income, or cancer type.
We partner with pharmaceutical companies, CROs, and healthcare institutions to accelerate oncology trial enrollment, reduce dropout rates, and deliver real-world evidence.
💠 160K+ patients onboarded
💠 45+ pharma and CRO customers
💠 130+ strategic partners
💠 Founding member of CancerX & participant in the White House Cancer Moonshot
Explore how we simplify trial access and optimize recruitment across the oncology ecosystem.
🔗 Learn more: www.massivebio.com
Company Details
- Employees
- 104
- Founded
- -
- Address
- Istanbul, Tr
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- http://www.massivebio.com
- Keywords
- Targeted cancer therapies, Cancer genomics, Tumor profiling technologies, Clinical trial selection, Second Opinion, Cancer Treatment, precision oncology, personalized cancer treatment options, Oncology, Cancer Care, Cancer Research.
- HQ
- Istanbul
Massive Bio Questions
Massive Bio's website is http://www.massivebio.com
Massive Bio's LinkedIn profile is https://www.linkedin.com/company/massivebio
Massive Bio has
104 employees.
View email and phone details for 104
employees at Massive Bio.
Massive Bio's industry is
Hospitals and Health Care
Massive Bio's top competitors are
Codeway,
Insider.,
Sanofi,
Massive Bioinformatics,
Nucleus Genetik Ürünleri A.ş.,
Bottobo Robotics,
Crs Soft,
Bayer,
Midas,
Pfizer.
Massive Bio's categories are Hospitals and Health Care
Massive Bio's founding year is 2014
